IBM’s Big Data and Analytics portfolio needs more tailoring for life sciences

Andrew Brosnan, Senior Analyst, Health Sciences

At its recent Big Data and Analytics Analyst Insights Summit in Toronto, IBM laid out its portfolio of technologies and services specifically for business analytics. The portfolio is a robust and comprehensive offering, encompassing all types of analytics, with specific tools and technologies across the “stack” for organizations of all sizes.

The phrase “easy, fast, and smart” was a recurring theme throughout the event, highlighting IBM’s commitment to providing a broad array of analytical tools and technologies that are easy to use and fast.

For many analytics vendors in a Big Data age this has been a rally cry, but IBM is well positioned to provide such capabilities to life science organizations because of the breadth of its expertise and the depth of its research and development (R&D).

Life science companies are faced with increasing volumes of fast-moving and diverse data (Big …